Roy Geoffrey Sargent

Roy Geoffrey Sargent is a declared insider of GeneTether Therapeutics Inc., with filings sourced from SEDI. Between 21 March 2022 and 18 October 2023, the trades on record add up to 2 filings.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 20 October 2023, reports a transaction in GeneTether Therapeutics Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.